Fast gene test for breast cancer diagnosis in Tanzania
Part of Cancer, Skin clinical trials.
This trial tests a new, fast method to diagnose breast cancer using a gene sequencing technique called nanopore sequencing. It aims to give accurate results quickly from a tumor sample taken during a biopsy or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected breast cancer diagnosis and need a biopsy or surgery.
- You have enough tumor tissue for testing.
- You have not started cancer treatment yet (herbal remedies are okay).
- You are able to give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a noninvasive test to look for signs of cancer in people newly diagnosed with certain cancers. It aims to see whether the test can help detect or identify cancer before treatment starts.
This trial tests a blood test that looks for chemical changes in DNA to help diagnose breast cancer. It may offer a simpler way to detect cancer without needing a tissue sample.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study tests a new ultra-rapid genetic test for BRCA1/2 mutations in people recently diagnosed with breast cancer. It aims to see if the faster result helps doctors and patients make treatment decisions sooner.
This trial uses whole genome sequencing, a test that reads the complete set of your DNA, to study breast cancer tissue. This may help doctors learn more about the disease and find better treatments.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
Hear when a new Breast Cancer Invasive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.